Catalyst Pharmaceuticals (CPRX) Other Gross PP&E Adjustments (2016 - 2025)
Catalyst Pharmaceuticals' Other Gross PP&E Adjustments history spans 14 years, with the latest figure at -$10.8 million for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 15.55% year-over-year to -$10.8 million; the TTM value through Dec 2025 reached -$10.8 million, up 15.55%, while the annual FY2025 figure was -$10.8 million, 15.55% up from the prior year.
- Other Gross PP&E Adjustments reached -$10.8 million in Q4 2025 per CPRX's latest filing, up from -$11.5 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$1.4 million in Q1 2024 to a low of -$29.8 million in Q1 2025.
- Average Other Gross PP&E Adjustments over 5 years is -$7.6 million, with a median of -$3.0 million recorded in 2021.
- Peak YoY movement for Other Gross PP&E Adjustments: plummeted 24902.05% in 2021, then surged 42.67% in 2023.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$3.0 million in 2021, then soared by 39.65% to -$1.8 million in 2022, then plummeted by 276.76% to -$6.7 million in 2023, then plummeted by 89.92% to -$12.8 million in 2024, then rose by 15.55% to -$10.8 million in 2025.
- Per Business Quant, the three most recent readings for CPRX's Other Gross PP&E Adjustments are -$10.8 million (Q4 2025), -$11.5 million (Q3 2025), and -$19.7 million (Q2 2025).